Zymeworks Inc. reported strong Q3 2026 results, driven by a $250 million milestone payment following FDA approval of Ziihera for first-line HER2-positive gastroesophageal adenocarcinoma. The company also completed the acquisition of Theravance Biopharma, adding recurring commercial revenue and expanding its portfolio. As a result, Zymeworks raised its 2026 revenue guidance to $337-$351 million and adjusted EBITDA to $176-$190 million. A collaboration with Roche for ZW209 is pending regulatory clearance, and the company plans an R&D Day in February 2027 to showcase its pipeline and strategy.
Zymeworks' corporate update and Q3 2026 results provide context for readers. For those tracking the health sector, 125 of 150 US health stocks on Pluang rose while 23 fell. Notable movers include DNA at USD 12.41 with a 9.92% increase and 100% buy order activity, SMMT at USD 17.90 up 9.61% with 98% buy orders, and FLNA at USD 0.50 rising 9.52% despite 88% sell orders. Data is as of Nov 10, 2026 04:11 WIB.
AmpliTech Group, a company specializing in RF and microwave components for telecom and defense, will announce its third quarter 2026 financial results on November 12, 2026, after market close. The company will host a conference call at 5:00 PM ET the...
Toll Brothers has announced the grand opening of new luxury single-story model homes at Hidden Vista, a gated community in Palm Desert, California, on November 14. These homes offer up to 2,700 sq ft with 3-4 bedrooms, modern open floor plans, and pr...
FocusReactive, a web development agency specializing in Next.js and headless CMS, achieved top rankings across six major industry review platforms in 2026, including Clutch, DesignRush, and The Manifest. The agency was recognized globally for experti...
Indonesia's e-commerce market is projected to grow from $120.2 billion in 2027 to $239.4 billion by 2032, with a CAGR of 14.78%. Growth is fueled by rising mobile commerce adoption, live-stream shopping, digital payment solutions like PayLater, and e...
Security National Financial Corporation reported a 38.6% drop in after-tax earnings for Q3 2026, falling to $6.17 million due to challenging mortgage market conditions and increased interest rates. The mortgage segment faced a $2.65 million loss driv...
